SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-013654
Filing Date
2022-02-08
Accepted
2022-02-08 16:01:28
Documents
1
Group Members
WUXI APPTEC (HONG KONG) HOLDING LTDWUXI APPTEC CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm225108d1_sc13g.htm SC 13G 85186
  Complete submission text file 0001104659-22-013654.txt   86979
Mailing Address BUILDING NO. 1, 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address BUILDING NO. 1, 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-50462227
WuXi PharmaTech Healthcare Fund I L.P. (Filed by) CIK: 0001678057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92634 | Film No.: 22601538
SIC: 2836 Biological Products, (No Diagnostic Substances)